Search research articles
Contact Us
Filters
Showing results (271-280 of 285) with videos related to
Page
of 29
Sort By:
Gut Microbes
|
September 20, 2021
SPI2 T3SS effectors facilitate enterocyte apical to basolateral transmigration of <i>Salmonella</i>-containing vacuoles <i>in vivo</i>
Marcus Fulde, Kira van Vorst, Kaiyi Zhang, et al.
Nature Medicine
|
April 6, 2010
Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia
Franck Lebrin, Samly Srun, Karine Raymond, et al.
Cell Reports
|
November 18, 2020
Triple RNA-Seq Reveals Synergy in a Human Virus-Fungus Co-infection Model
Bastian Seelbinder, Julia Wallstabe, Lothar Marischen, et al.
Frontiers in Genetics
|
March 28, 2015
Genetic variation in the functional ENG allele inherited from the non-affected parent associates with presence of pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia 1 (HHT1) and may influence expression of PTPN14
Tom G W Letteboer, Michael Benzinou, Christopher B Merrick, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 10, 2014
Genetic variants of Adam17 differentially regulate TGFβ signaling to modify vascular pathology in mice and humans
Kyoko Kawasaki, Julia Freimuth, Dominique S Meyer, et al.
Circulation
|
November 8, 2006
Endoglin has a crucial role in blood cell-mediated vascular repair
Linda W van Laake, Sander van den Driesche, Simone Post, et al.
Human Mutation
|
April 29, 1998
Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles
C J Gallione, D J Klaus, E Y Yeh, et al.
Nature Communications
|
January 12, 2012
Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia
Michael Benzinou, Frederic F Clermont, Tom G W Letteboer, et al.
Leukemia
|
February 8, 2019
Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine
R F Schlenk, D Weber, W Herr, et al.
Annals of Hematology
|
November 2, 2017
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)
Gabriele Nagel, D Weber, E Fromm, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 285) with videos related to
Sort By:
Page
of 29
Gut Microbes
|
September 20, 2021
SPI2 T3SS effectors facilitate enterocyte apical to basolateral transmigration of <i>Salmonella</i>-containing vacuoles <i>in vivo</i>
Marcus Fulde, Kira van Vorst, Kaiyi Zhang, et al.
Nature Medicine
|
April 6, 2010
Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia
Franck Lebrin, Samly Srun, Karine Raymond, et al.
Cell Reports
|
November 18, 2020
Triple RNA-Seq Reveals Synergy in a Human Virus-Fungus Co-infection Model
Bastian Seelbinder, Julia Wallstabe, Lothar Marischen, et al.
Frontiers in Genetics
|
March 28, 2015
Genetic variation in the functional ENG allele inherited from the non-affected parent associates with presence of pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia 1 (HHT1) and may influence expression of PTPN14
Tom G W Letteboer, Michael Benzinou, Christopher B Merrick, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 10, 2014
Genetic variants of Adam17 differentially regulate TGFβ signaling to modify vascular pathology in mice and humans
Kyoko Kawasaki, Julia Freimuth, Dominique S Meyer, et al.
Circulation
|
November 8, 2006
Endoglin has a crucial role in blood cell-mediated vascular repair
Linda W van Laake, Sander van den Driesche, Simone Post, et al.
Human Mutation
|
April 29, 1998
Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles
C J Gallione, D J Klaus, E Y Yeh, et al.
Nature Communications
|
January 12, 2012
Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia
Michael Benzinou, Frederic F Clermont, Tom G W Letteboer, et al.
Leukemia
|
February 8, 2019
Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine
R F Schlenk, D Weber, W Herr, et al.
Annals of Hematology
|
November 2, 2017
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)
Gabriele Nagel, D Weber, E Fromm, et al.
Page
of 29